Faraday Hosseinipour’s I2G Retrial Motion Remanded to District Court
On July 1, 2025, the Sixth Circuit Court of Appeals affirmed Faraday Hosseinipour’s conviction for her role as a top promoter in the Infinity2Global (I2G) Ponzi scheme, alongside co-defendants Richard Maike and Doyce Barnes. However, the court vacated the District Court’s denial of her Rule 33 motion for a new trial, remanding it for reconsideration. This latest development marks a key turn in the Faraday Hosseinipour I2G Retrial, though the court’s reasoning remains unpublished.
I2G’s Deceptive Practices Exposed
Hosseinipour, convicted in September 2022 of conspiracy to commit mail fraud and securities fraud, misrepresented I2G as a legitimate MLM offering “passive income” without recruitment. She falsely claimed celebrity endorsements, including Prince for I2G’s Songstergram, and displayed oversized checks inflating her earnings. When a distributor accused I2G of being a pyramid scheme, Hosseinipour suggested silencing them, per court records. I2G, launched by Maike in 2013, defrauded investors of $25 million through fake casino and software ventures.
Convictions Final, Retrial in Limbo
Maike (10 years) and Barnes (4 years) had their sentences finalized, with restitution set at $5.2 million and $3.92 million, respectively, plus $1.29 million to the IRS for Maike. Hosseinipour, sentenced to 2.5 years in January 2023 and ordered to pay $3.92 million, was released on October 10, 2023, pending her appeal, after arguing ineffective counsel (her attorney, her husband’s brother, lacked federal trial experience). The Sixth Circuit’s remand suggests potential issues with the District Court’s handling of her retrial motion, though a new conviction seems likely given the affirmed evidence.
Uncertain Outcome
The unpublished reasoning behind the remand leaves the retrial’s prospects unclear. With overwhelming evidence from over 30 DOJ witnesses, Hosseinipour’s chances of overturning her conviction appear slim. The District Court’s forthcoming ruling will determine if a new trial proceeds.